Efficacy of the Hepcon system in reducing hemorrhagic and thrombotic complications in antiphospholipid syndrome patients undergoing cardiac surgery.

Blood(2023)

引用 0|浏览7
暂无评分
摘要
There was no difference in the composite outcome of thrombotic or hemorrhagic complications in patients monitored by Hepcon versus those monitored by ACT.
更多
查看译文
关键词
Antiphospholipid antibody syndrome,hemorrhagic disorders and therapies,thrombotic disorders
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要